from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3476c/kgtP

LFCtreatmentdescriptionclass of inhibitor

-0.327

Amikacinug/mL Amikacintranslation

0.524

Cap5-10ug/mL Capreomycintranslation

0.201

Rox10-50 ug/mL Roxithromycintranslation

0.266

SM2-5 ug/mL Streptomycintranslation

1.686

Tet5-10 ug/mL Tetracyclinetranslation

0.118

Rif0.2-5ug/mL Rifampicintranscription

1.097

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.540

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.495

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.010

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.096

Clofazimine10-13 ug/mL Clofaziminerespiration

0.467

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.016

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.831

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.404

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.908

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.156

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.503

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.890

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.043

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.977

KCN5-20 ug/mL Potassium cyaniderespiration

-0.261

NaN30.2-2 mM Sodium aziderespiration

0.777

Nigericin50 uM Nigericinrespiration

-0.542

TRC10-150 ug/mL Triclosanrespiration

-0.700

TRZ10-25 ug/mL Thioridazinerespiration

-1.621

Valinomycin0.5-10 uM Valinomycinrespiration

-0.343

ZnSO42 mM ZnSO4respiration

-1.413

menadione6-10 ug/mL Menadionerespiration

0.406

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.641

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.279

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.205

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.900

NRP_1Non-replicating persistence stage 1dosRassociated

-0.504

Amp0.2mg/mL AmpicillincellWall

0.210

Cephalexin20-100 ug/mL CephalexincellWall

0.670

Cerulenin0.32-5 ug/mL CerulenincellWall

0.366

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.302

EMB10-20 ug/mL EthambutolcellWall

0.214

Eta12-40 ug/mL EthionamidecellWall

0.395

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.829

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.451

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.547

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.439

BZA0.12 mg/mL BenzamidearomaticAmides

0.485

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.919

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.049

H2O24 mM hydrogen peroxideDNAdamaging

0.167

Levo10 ug/mL LevofloxacinDNAdamaging

0.189

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.003

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.052

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.233

UVUV-irradiationDNAdamaging

-1.797

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.192

Antimycin12.5-50 ug/mL Antimycin A?

0.671

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.342

PA_110-50 ug/mL Antitubercular compound PA-1?

0.239

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.197

PA8240.2-2 ug/mL PA-824?

-1.069

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.435

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.458

Verapamil50 uM Verapamil?

0.059

mercaptoethanol2 mM 2-Mercaptoethanol?

0.299

methoxatin10-20 ug/mL Methoxatin?